The potential of mitochondrial genome engineering

P Silva-Pinheiro, M Minczuk - Nature Reviews Genetics, 2022 - nature.com
Mitochondria are subject to unique genetic control by both nuclear DNA and their own
genome, mitochondrial DNA (mtDNA), of which each mitochondrion contains multiple …

Mechanisms of mesenchymal stem/stromal cell function

JL Spees, RH Lee, CA Gregory - Stem cell research & therapy, 2016 - Springer
The past decade has seen an explosion of research directed toward better understanding of
the mechanisms of mesenchymal stem/stromal cell (MSC) function during rescue and repair …

Capsid modifications for targeting and improving the efficacy of AAV vectors

H Büning, A Srivastava - Molecular therapy Methods & clinical development, 2019 - cell.com
In the past decade, recombinant vectors based on a non-pathogenic parvovirus, the adeno-
associated virus (AAV), have taken center stage as a gene delivery vehicle for the potential …

Therapies for mitochondrial diseases and current clinical trials

AW El-Hattab, AM Zarante, M Almannai… - Molecular genetics and …, 2017 - Elsevier
Mitochondrial diseases are a clinically and genetically heterogeneous group of disorders
that result from dysfunction of the mitochondrial oxidative phosphorylation due to molecular …

Gene therapy for Leber hereditary optic neuropathy: initial results

WJ Feuer, JC Schiffman, JL Davis, V Porciatti… - Ophthalmology, 2016 - Elsevier
Purpose Leber hereditary optic neuropathy (LHON) is a disorder characterized by severe
and rapidly progressive visual loss when caused by a mutation in the mitochondrial gene …

A comprehensive review of retinal gene therapy

SE Boye, SL Boye, AS Lewin, WW Hauswirth - Molecular therapy, 2013 - cell.com
Blindness, although not life threatening, is a debilitating disorder for which few, if any
treatments exist. Ocular gene therapies have the potential to profoundly improve the quality …

Mitochondria-targeted drugs

RA Zinovkin, AA Zamyatnin - Current Molecular Pharmacology, 2019 - ingentaconnect.com
Background: Targeting of drugs to the subcellular compartments represents one of the
modern trends in molecular pharmacology. The approach for targeting mitochondria was …

Leber hereditary optic neuropathy: current perspectives

C Meyerson, G Van Stavern… - Clinical …, 2015 - Taylor & Francis
Leber hereditary optic neuropathy (LHON) is one of the most common inherited optic
neuropathies causing bilateral central vision loss. The disorder results from point mutations …

Basic biology of adeno-associated virus (AAV) vectors used in gene therapy

B Balakrishnan, G R. Jayandharan - Current gene therapy, 2014 - benthamdirect.com
Adeno-associated virus (AAV) based vectors have emerged as important tools for gene
therapy in humans. The recent successes seen in Phase I/II clinical trials have also …

The family Narnaviridae: simplest of RNA viruses

BI Hillman, G Cai - Advances in virus research, 2013 - Elsevier
Members of the virus family Narnaviridae contain the simplest genomes of any RNA virus,
ranging from 2.3 to 3.6 kb and encoding only a single polypeptide that has an RNA …